Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Reference-Cited by-同舟云学术

Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes

Published:2013-04 Issue:4 Volume:19 Page:562-568
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Krishnamurthy Pramila,Potter Victoria T.,Barber Linda D.,Kulasekararaj Austin G.,Lim Zi Yi,Pearce Rachel M.,de Lavallade Hugues,Kenyon Michelle,Ireland Robin M.,Marsh Judith C.W.,Devereux Stephen,Pagliuca Antonio,Mufti Ghulam J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials;Koreth;JAMA,2009

2. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review;Oliansky;Biol Blood Marrow Transplant,2009

3. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia;Valcarcel;Curr Opin Oncol,2007

4. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

5. Reduced-intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia;Ringden;J Clin Oncol,2009

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking Boundaries: Immunotherapy for Myeloid Malignancies;Cancers;2024-08-06

2. Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34+ and CD3+ donor chimerism (DC) monitoring;Leukemia Research;2024-07

3. Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation;Journal of Clinical Oncology;2024-04-20

4. How I reduce and treat posttransplant relapse of MDS;Blood;2024-04-04

5. Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients;Cancers;2024-03-26